- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Corporates help eGenesis generate $125m
Xenotransplantation technology developer eGenesis took its total funding to $263m in a series C round backed by Bayer and Fresenius Medical Care.
Mar 3, 2021FogPharma finds $107m in series C
GV returned for a series C round that helped the precision cancer medicine developer increase its overall funding to over $180m.
Mar 3, 2021Olympus eyes Medi-Tate acquisition
Laborie is set to exit the medical device manufacturer after another of its investors, Olympus, announced its intention to pay $260m for its remaining shares.
Mar 3, 2021ACV Auctions aims for $100m in IPO
Online car dealership service ACV Auctions has filed to go public having previously raised some $360m in funding from investors including SoftBank.
Mar 3, 2021Artizan crafts $11m series A2
Osage University Partners has thrown its weight behind a series A2 round for Artizan, which is advancing work undertaken at Yale University.
Mar 3, 2021Artizan crafts $11m series A2 round
Biohaven Therapeutics co-led Artizan Biosciences' latest round as part of an option and licensing agreement focusing on its inflammatory bowel disease drug candidates.
Mar 3, 2021Osage helps orchestrate eGenesis series C
Xenotransplantation technology developer eGenesis has raised $125m in a series C round backed by Osage University Partners.
Mar 3, 2021Genomics gets its hands on $30m
The Vertex Pharmaceuticals-backed genomic analytics platform developer has now raised approximately $88m in funding altogether.
Mar 3, 2021Investors bet on Rivalry in $20m round
An unnamed casino operator invested in the sports and esports betting platform developer in around that will support international expansion.
Mar 2, 2021ClickPaas adds series B funding
The low-code app app development software provider's eight-figure round included BAI and SIG Asia.
Mar 2, 2021Reliance levitates to SkyTran acquisition
Reliance paid $26.8m to gain majority control of the passive magnetic levitation and propulsion technology developer and now owns 54.5% of its shares.
Mar 2, 2021Gitai gets series B cash
Seiko Epson’s EP-GB fund and Dai-ichi Life helped provide $17.1m for Gitai as it prepares a demonstration of its space robotics technology.
Mar 2, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


